Levodopa and melanoma: three cases and review of literature.
- 1 June 1985
- journal article
- case report
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 48 (6) , 585-588
- https://doi.org/10.1136/jnnp.48.6.585
Abstract
Three patients are reported who developed a melanoma while taking levodopa for Parkinson's disease. There were two cutaneous melanomas and one metastatic melanoma with occult primary. The literature on the association of Parkinson's disease, levodopa therapy and melanoma is reviewed. The capacity of levodopa to induce melanomas and its alleged adverse effect on the clinical course of the disease are questioned.Keywords
This publication has 16 references indexed in Scilit:
- Choroidal Melanoma and LevodopaJAMA, 1984
- Malignant melanoma and levodopa.1984
- Uveal Malignant Melanoma and Levodopa Therapy in Parkinson’s DiseaseOphthalmology, 1982
- Levodopa and melanomaJAMA, 1979
- [Connection between levodopa therapy and malignant tumors].1979
- Epidermotropically metastatic malignant melanoma. Differentiating malignant melanoma metastatic to the epidermis from malignant melanoma primary in the epidermisArchives of Dermatology, 1978
- L-Dopa: Selective Toxicity for Melanoma Cells in VitroScience, 1977
- Parkinson's disease, melanoma, and levodopaZeitschrift für Neurologie, 1977
- Levodopa and melanomaNeurology, 1974
- Multiple primary melanoma following administration of levodopa.1972